Target intelligence / Profile preview

Urothelial tissue repair

Molecular classification
Other
01

Overview

Urothelial tissue repair is a multifaceted physiological process involving the regeneration of the specialized epithelial lining of the urinary tract following injury, infection, or chronic inflammation. Although the urothelium is typically characterized by exceptionally low cell turnover, it possesses a robust regenerative capacity mediated by progenitor cell populations, such as KRT5+ and KRT14+ basal cells, which proliferate and differentiate to restore the protective permeability barrier. This repair mechanism is regulated by a complex network of signaling pathways, including Sonic Hedgehog (SHH), Bone Morphogenetic Protein 4 (BMP4), Wnt ligands, and Peroxisome Proliferator-Activated Receptor gamma (PPARγ), which coordinate the transition from a proliferative state to a fully differentiated, barrier-forming state. Therapeutic interventions in this area aim to facilitate healing by replenishing the glycosaminoglycan (GAG) layer or by modulating growth factor signaling to enhance natural regenerative processes. Clinically, managing and promoting urothelial repair is essential for treating conditions like interstitial cystitis, urinary tract infections, and bladder injuries resulting from surgery or radiation.

Other names
Urothelial regenerationUrothelial healingBladder mucosal repairUrothelial wound healingUrothelial barrier restoration
02

Mechanism of action

Restoration of the protective glycosaminoglycan (GAG) layer; activation of basal progenitor cells through growth factor and transcription factor signaling (e.g., PPARγ, SHH); and modulation of the inflammatory environment to support epithelial proliferation and differentiation.

03

Biological functions

Cell proliferationCell differentiationTissue remodelingSignal transductionWound healingEpithelial-to-mesenchymal transition
04

Disease associations

Interstitial cystitisBladder cancerUrinary tract infectionCystitisUrinary tract obstruction
05

Safety considerations

Risk of tissue fibrosis or scarring from excessive repair activityPotential for malignant transformation if proliferative pathways are chronically or inappropriately activatedTherapeutic challenges in achieving localized delivery of agents to the bladder mucosa
06

Interacting drugs

Pentosan polysulfate sodium

4 more in the full profile.

07

Biomarkers

Uroplakin II (UPK2)Uroplakin III (UPK3A)Cytokeratin 5 (KRT5)Cytokeratin 20 (KRT20)Heparin-binding EGF-like growth factor (HB-EGF)

Beyond the preview

Go deeper on Urothelial tissue repair.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urothelial tissue repair.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call